Impact ledger
Taysha Gene Therapies, Inc. (TSHA)
3 events mapped to this ticker since 2026-06-22.
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-06-29 | Event | Indirect validation of gene therapy for neurological disorders and potential for increased investor interest in the broader gene therapy sector, particularly for rare neurological diseases. Taysha also focuses on CNS gene therapies. | watch | 1-3m | 0.30 |
| 2026-06-22 | Event | Direct progress in lead clinical asset, de-risking development timeline, and moving closer to commercialization. | Bullish | 1-3m | 0.80 |
| 2026-06-22 | Event | Successful completion of dosing in a pivotal trial significantly de-risks the clinical development pathway, moving closer to potential regulatory submission and commercialization. This milestone can increase investor confidence and reduce perceived R&D risk. | Bullish | 3-12m | 0.90 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for TSHA, start a trial or view the TSHA entity page.